Page 1397 - Problem-Based Feline Medicine

20 – THE CAT WITH ENLARGED LYMPH NODES 13891389
DRUG INDEX

loading dose (in 3 mg/kg increments) to adjust 6 h h (discontinue when phosphorus > 2 mg/dl) h (discontinue when phosphorus > 2 mg/dl) Continued

to effect 6 7 days 8–12 sid 24 2 24 × 1 24 × 12; monitor dose 12 12 12 8–12 24 12 PRN 8 8 24 24 over per per

IV, PO IM, SC IM, SC IM, SC PO, IM, IV IV, PO slowly
IV IV PO PO PO PO PO PO PO IV PO PO IV IV PO PO PO PO IV IV IV

5–15 mg/kg 2–4 mg/kg 25 mg/kg 3 mg/kg 100 mg/cat 10–15 mg/kg 1–5 ml/cat 7.5 mg/kg 15 mg/kg 2–30 mg/kg 1–2 mg/kg 1 mg/kg 4–8 mg 0.5 mg/kg 2.5–10 mg/cat 0.5 mg/kg 2.5–10.0 mg/cat 0.5 mg/cat 0.02–0.1 mg/kg 0.15 mg/kg 1.5–2.0 mg/kg 12.5 mg/cat 75 mg (sustained release) 2–3 mg/kg 4.5 mg/dl serum phosphate 0.06–1.80 mM/kg 0.01–0.03 mM/kg

Status epilepticus, sedation Sedation Disease modifying agent: arthritis Dermatomyositis Immune-mediated dermatologic diseases See bismuth subsalicylate Laxative Babesiosis Status epilepticus Maintenance Sedation Psychogenic alopecia Acute hypertension from pheochromocytoma areflexia Detrusor Relaxation of urinary sphincter Endotoxemia Hypertension from pheochromocytoma Vasopressor incompe

Pentobarbital Pentosan polysulfate Pentoxifylline Pepto bismol Petrolatum,white Phenamidine isethionate Phenobarbital Phenoxybenzamine HCl Phentolamine Phenylephrine Phenylpropanolamine HCl Phenytoin Na) Phosphate (K or